Aurobindo Pharma receives tentative approval for AIDS drug

From USFDA

Aurobindo Pharma has received tentative approval from USFDA under U.S. President's Emergency Plan for AIDS Relief for its New Drug Application for Dolutegravir, Lamivudine & Tenofovir Disoproxil Fumarate tablets, 50 mg/ 300 mg/ 300mg. The triple combination product is expected to be launched in sub-Saharan Africa in Q3 FY 2018.

Powered by Capital Market - Live News